Filtered By:
Condition: Autoimmune Disease

This page shows you your search results in order of relevance. This is page number 2.

Order by Relevance | Date

Total 584 results found since Jan 2013.

Herpes Zoster and the Risk for Stroke in Patients with Autoimmune Diseases
Conclusion: In patients with autoimmune diseases, incident HZ was associated with up to a two‐fold increased risk for stroke in the subsequent few months. These data provide urgency for developing strategies to reduce the risk of VZV. This article is protected by copyright. All rights reserved.
Source: Arthritis and Rheumatism - September 1, 2016 Category: Rheumatology Authors: L.H. Calabrese, F. Xie, H. Yun, K. Winthrop, J.W. Baddley, C. Calabrese, J.R. Curtis Tags: Full Length Source Type: research

Herpes Zoster and the Risk of Stroke in Patients With Autoimmune Diseases
ConclusionIn patients with autoimmune diseases, incident HZ was associated with as much as a 2‐fold increased risk of stroke in the subsequent few months. These data underscore the urgency of developing strategies for reducing the risk of varicella‐zoster virus.
Source: Arthritis and Rheumatism - January 27, 2017 Category: Rheumatology Authors: Leonard H. Calabrese, Fenglong Xie, Huifeng Yun, Kevin L. Winthrop, John W. Baddley, Cassandra Calabrese, Jeffrey R. Curtis Tags: Autoimmune Disease Source Type: research

Expression of Cytokines and Chemokines as Predictors of Stroke Outcomes in Acute Ischemic Stroke
Conclusions: Machine learning algorithms can be employed to develop prognostic predictive biomarkers for stroke outcomes in ischemic stroke patients, particularly in regard to identifying acute gene expression changes that occur during stroke.
Source: Frontiers in Neurology - January 14, 2020 Category: Neurology Source Type: research

Increased risk of ischaemic stroke among patients with multiple sclerosis
ConclusionsMultiple sclerosis is declared to be associated with an increased risk in developing stroke, which requires closer attention to this group of patients for stroke prevention, especially in the younger population.
Source: European Journal of Neurology - November 29, 2014 Category: Neurology Authors: C.‐H. Tseng, W.‐S. Huang, C.‐L. Lin, Y.‐J. Chang Tags: Original Article Source Type: research

Stroke In Young Adults: A 4-Year Retrospective Hospital-Based Study, First Report From United Arab Emirates (P1.020)
CONCLUSIONS: Stroke in young adults is prevalent in our region; main cause is unknown. The increased mortality in this age population is alarming requiring better risk-factor control measures. MR: Mortality rates, ICH: intracerebral hemorrhage, SAH: subarachnoid hemorrhageDisclosure: Dr. AlAmeri has nothing to disclose. Dr. AlNuaimi has nothing to disclose. Dr. Alsaadi has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: AlAmeri, M., AlNuaimi, A., Alsaadi, T. Tags: Cerebrovascular Disease and Interventional Neurology I ePosters Source Type: research

Partial MHC class II constructs as novel immunomodulatory therapy for stroke
Publication date: Available online 31 October 2016 Source:Neurochemistry International Author(s): Gil Benedek, Arthur A. Vandenbark, Nabil J. Alkayed, Halina Offner The worldwide prevalence of stroke continues to rise despite recent successes in treating acute ischemic stroke. With limited patient eligibility and associated risk of tPA and mechanical thrombectomy, new preventive and therapeutic modalities are needed to stave the rising wave of stroke. Inflammation plays a key role in brain damage after cerebral ischemia, and novel therapies that target pro-inflammatory cells have demonstrated promise for treatment for str...
Source: Neurochemistry International - October 31, 2016 Category: Neuroscience Source Type: research

Regulatory B cells in Experimental Stroke.
This article is protected by copyright. All rights reserved. PMID: 29313944 [PubMed - as supplied by publisher]
Source: Immunology - January 3, 2018 Category: Allergy & Immunology Authors: Seifert HA, Vandenbark AA, Offner H Tags: Immunology Source Type: research

Increased levels of antibodies against heat shock proteins in stroke patients.
In this study we determined the antibody levels against bacterial and human Hsp by ELISA in blood plasma obtained from stroke patients. Using ANOVA we analyzed levels of Hsp-antibodies in control and patient groups and correlate them with several stroke risk factors. The group of stroke patients had elevated levels of anti-Hsp antibodies compared to the control group. We also discovered an antibody level increase in patients that previously underwent another stroke. Our data provide evidence that autoimmunity could underlie formation of atherosclerosis plaque leading to stroke. PMID: 24904931 [PubMed - as supplied by publisher]
Source: Acta Biochim Pol - June 6, 2014 Category: Biochemistry Authors: Banecka-Majkutewicz Z, Grabowski M, Kadziński L, Papkov A, Węgrzyn A, Banecki B Tags: Acta Biochim Pol Source Type: research

A Case of Fabry Disease Presenting with Young Stroke and Fever.
Authors: Wu LC, Chiang CT, Lee KF Abstract Although it is known that Fabry disease should be included in the differential diagnosis of young stroke and fever of unknown origin, it has not been reported in the literature of stroke with fever as the presentation of Fabry disease. This is relevant because stroke with fever may misguide the differential diagnosis. Here we present a young stroke patient with fever. DWI of brain MRI revealed acute multiple infarctions. Due to the fever, infectious and inflammatory origins such as infective endocarditis and autoimmune diseases were examined first. However, we could not id...
Source: Acta Neurologica Taiwanica - December 25, 2019 Category: Neurology Tags: Acta Neurol Taiwan Source Type: research

Regulatory T lymphocytes as a therapy for ischemic stroke
AbstractUnrestrained excessive inflammatory responses exacerbate ischemic brain injury and impede post-stroke brain recovery. CD4+CD25+Foxp3+ regulatory T (Treg) cells play important immunosuppressive roles to curtail inflammatory responses and regain immune homeostasis after stroke. Accumulating evidence confirms that Treg cells are neuroprotective at the acute stage after stroke and promote brain repair at the chronic phases. The beneficial effects of Treg cells are mediated by diverse mechanisms involving cell –cell interactions and soluble factor release. Multiple types of cells, including both immune cells and non-i...
Source: Seminars in Immunopathology - December 5, 2022 Category: Pathology Source Type: research

Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
CONCLUSIONS: There is not enough evidence for or against NOACs or for high-intensity VKA compared to the standard VKA therapy in the secondary prevention of thrombosis in people with APS. There is some evidence of harm for high-intensity VKA regarding minor and any bleeding. The evidence was also not sufficient to show benefit or harm for VKA plus antiplatelet agent or dual antiplatelet therapy compared to a single antiplatelet drug. Future studies should be adequately powered, with proper adherence to treatment, in order to evaluate the effects of anticoagulants, antiplatelets, or both, for secondary thrombosis prevention...
Source: Cochrane Database of Systematic Reviews - October 2, 2017 Category: General Medicine Authors: Bala MM, Celinska-Lowenhoff M, Szot W, Padjas A, Kaczmarczyk M, Swierz MJ, Undas A Tags: Cochrane Database Syst Rev Source Type: research

Stroke among Rheumatoid Arthritis Patients: Does Age Matter A Real-Life Study
Conclusion: RA is independently associated with stroke, especially among RA patients under 65 years, for whom cardiovascular risk factors were more prominent. Physicians should advise RA patients to manage their risk factors strictly.Neuroepidemiology 2017;49:99 –105
Source: Neuroepidemiology - November 14, 2017 Category: Epidemiology Source Type: research

Interleukin-17 and ischemic stroke.
Abstract Interleukin-17 (IL-17) is a cytokine family that includes 6 members, IL-17A through IL-17F, most of them are reported to have pro-inflammatory role. Through binding to their receptors (IL-17Rs), IL-17 activates the intracellular signaling pathways to play an important role in autoimmune diseases, including rheumatoid arthritis (RA) and multiple sclerosis (MS). Ischemic stroke is a complex pathophysiological process mainly caused by regional cerebral ischemia. Inflammatory factors contribute to the physiological process of stroke that leads to poor prognosis. IL-17 plays a crucial role in promoting inflamm...
Source: Immunology - September 15, 2020 Category: Allergy & Immunology Authors: Zhang Q, Liao Y, Liu Z, Dai Y, Li Y, Li Y, Tang Y Tags: Immunology Source Type: research

Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
CONCLUSIONS: The evidence identified indicates that NOACs compared with standard-dose VKAs may increase the risk of stroke and do not appear to alter the risk of other outcomes (moderate-certainty evidence). Using high-dose VKA versus standard-dose VKA did not alter the risk of any thromboembolic event or major bleeding but may increase the risk of any form of bleeding (low-certainty evidence). Standard-dose VKA combined with an AP agent compared with standard-dose VKA alone may increase the risk of any thromboembolic event and does not appear to alter the risk of major bleeding or other outcomes (low-certainty evidence). ...
Source: Cochrane Database of Systematic Reviews - October 12, 2020 Category: General Medicine Authors: Bala MM, Celinska-Lowenhoff M, Szot W, Padjas A, Kaczmarczyk M, Swierz MJ, Undas A Tags: Cochrane Database Syst Rev Source Type: research